Prudential Financial’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.28M | Buy |
77,408
+19,050
| +33% | +$1.05M | 0.01% | 1004 |
|
|
2025
Q1 | $2.82M | Sell |
58,358
-1,640
| -3% | -$79.3K | ﹤0.01% | 1127 |
|
|
2024
Q4 | $2.32M | Sell |
59,998
-800
| -1% | -$30.9K | ﹤0.01% | 1233 |
|
|
2024
Q3 | $2.74M | Buy |
+60,798
| New | +$2.74M | ﹤0.01% | 1297 |
|
|
2023
Q2 | – | Sell |
-67,293
| Closed | -$1.55M | – | 2691 |
|
|
2023
Q1 | $1.55M | Buy |
+67,293
| New | +$1.55M | ﹤0.01% | 1497 |
|
|
2022
Q2 | – | Sell |
-22,993
| Closed | -$544K | – | 2735 |
|
|
2022
Q1 | $544K | Sell |
22,993
-7,112
| -24% | -$168K | ﹤0.01% | 2168 |
|
|
2021
Q4 | $1.03M | Sell |
30,105
-190
| -0.6% | -$6.5K | ﹤0.01% | 1867 |
|
|
2021
Q3 | $537K | Buy |
30,295
+450
| +2% | +$7.98K | ﹤0.01% | 2117 |
|
|
2021
Q2 | $1.34M | Sell |
29,845
-3,770
| -11% | -$169K | ﹤0.01% | 1677 |
|
|
2021
Q1 | $871K | Sell |
33,615
-10,210
| -23% | -$265K | ﹤0.01% | 1898 |
|
|
2020
Q4 | $884K | Sell |
43,825
-11,190
| -20% | -$226K | ﹤0.01% | 1810 |
|
|
2020
Q3 | $1.08M | Sell |
55,015
-12,290
| -18% | -$240K | ﹤0.01% | 1609 |
|
|
2020
Q2 | $1.19M | Sell |
67,305
-5,035
| -7% | -$88.9K | ﹤0.01% | 1572 |
|
|
2020
Q1 | $511K | Buy |
72,340
+20,650
| +40% | +$146K | ﹤0.01% | 1905 |
|
|
2019
Q4 | $365K | Buy |
+51,690
| New | +$365K | ﹤0.01% | 2149 |
|
|
2018
Q3 | – | Sell |
-12,100
| Closed | -$81K | – | 2463 |
|
|
2018
Q2 | $81K | Sell |
12,100
-1,470
| -11% | -$9.84K | ﹤0.01% | 2398 |
|
|
2018
Q1 | $116K | Buy |
+13,570
| New | +$116K | ﹤0.01% | 2290 |
|